MYOZ2
Basic information
Region (hg38): 4:119135832-119187789
Previous symbols: [ "C4orf5" ]
Links
Phenotypes
GenCC
Source:
- hypertrophic cardiomyopathy 16 (Limited), mode of inheritance: AD
- hypertrophic cardiomyopathy 16 (Limited), mode of inheritance: AD
- hypertrophic cardiomyopathy 16 (Limited), mode of inheritance: AD
- hypertrophic cardiomyopathy (Disputed Evidence), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cardiomyopathy, familial hypertrophic, 16 | AD | Cardiovascular | Surveillance and preventive measures related to cardiac manifestations, which have been reported as including arrhythmias, may allow early diagnosis and medical management as well as pacemaker placement, which may reduce morbidity and mortality | Cardiovascular | 17347475; 19472918 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hypertrophic_cardiomyopathy (150 variants)
- Cardiovascular_phenotype (142 variants)
- not_provided (54 variants)
- not_specified (35 variants)
- Hypertrophic_cardiomyopathy_16 (30 variants)
- Cardiomyopathy (19 variants)
- MYOZ2-related_disorder (7 variants)
- Primary_familial_hypertrophic_cardiomyopathy (2 variants)
- Restrictive_cardiomyopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYOZ2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016599.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 52 | 55 | ||||
missense | 143 | 11 | 155 | |||
nonsense | 6 | |||||
start loss | 2 | 2 | ||||
frameshift | 5 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 0 | 1 | 160 | 63 | 3 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYOZ2 | protein_coding | protein_coding | ENST00000307128 | 5 | 52006 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00157 | 0.893 | 125721 | 0 | 24 | 125745 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.539 | 125 | 143 | 0.873 | 0.00000693 | 1746 |
Missense in Polyphen | 44 | 53.059 | 0.82927 | 647 | ||
Synonymous | -0.0712 | 49 | 48.4 | 1.01 | 0.00000225 | 498 |
Loss of Function | 1.41 | 6 | 11.1 | 0.543 | 5.63e-7 | 138 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000214 | 0.000213 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Myozenins may serve as intracellular binding proteins involved in linking Z line proteins such as alpha-actinin, gamma- filamin, TCAP/telethonin, LDB3/ZASP and localizing calcineurin signaling to the sarcomere. Plays an important role in the modulation of calcineurin signaling. May play a role in myofibrillogenesis.;
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- loftool
- 0.568
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 33.97
Haploinsufficiency Scores
- pHI
- 0.508
- hipred
- Y
- hipred_score
- 0.615
- ghis
- 0.525
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.323
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Myoz2
- Phenotype
- muscle phenotype; homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;skeletal muscle tissue development;biological_process;skeletal muscle fiber adaptation;sarcomere organization;negative regulation of calcineurin-NFAT signaling cascade
- Cellular component
- actin cytoskeleton;sarcomere;Z disc
- Molecular function
- actin binding;protein binding;protein phosphatase 2B binding;telethonin binding;FATZ binding